2018
DOI: 10.1016/bs.apcsb.2017.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Intramembrane Protein–Protein Interactions: Novel Therapeutic Strategy of Millions Years Old

Abstract: Intramembrane protein-protein interactions (PPIs) are involved in transmembrane signal transduction mediated by cell surface receptors and play an important role in health and disease. Recently, receptor-specific modulatory peptides rationally designed using a general platform of transmembrane signaling, the signaling chain homooligomerization (SCHOOL) model, have been proposed to therapeutically target these interactions in a variety of serious diseases with unmet needs including cancer, sepsis, arthritis, re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 231 publications
(304 reference statements)
0
1
0
Order By: Relevance
“…Other strategies to manipulate protein-protein interaction are based on the use of biologics tools. Interestingly, interfering peptides, antibodies, nanobodies as well as emerging oligonucleotide therapeutics such as aptamers have also been explored as new therapeutic agents [7,8]. However, this field of research remain very challenging.…”
Section: Introductionmentioning
confidence: 99%
“…Other strategies to manipulate protein-protein interaction are based on the use of biologics tools. Interestingly, interfering peptides, antibodies, nanobodies as well as emerging oligonucleotide therapeutics such as aptamers have also been explored as new therapeutic agents [7,8]. However, this field of research remain very challenging.…”
Section: Introductionmentioning
confidence: 99%